# A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers

> **NCT01592890** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** RO4917523
- **DRUG:** RO4917523

## Key facts

- **NCT ID:** NCT01592890
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01592890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01592890, "A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01592890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*